Asthma: Boehringer Ingelheim announces U.S. FDA filing acceptance of NDA for Spiriva < sup > ® < /sup > Respimat < sup > ® < /sup > in asthma

Asthma: Boehringer Ingelheim announces U.S. FDA filing acceptance of NDA for Spiriva < sup > ® < /sup > Respimat < sup > ® < /sup > in asthma
Source: Boehringer Ingelheim Corporate News - Category: Research Source Type: news